Rare Anemias

EHA2022 | Agios Presents New Data Supporting the Benefits of PYRUKYND®In Adults With PKD

Data were presented at the European Hematology Association (EHA) Annual Congress, hosted virtually and in person in Vienna on June 9-12, 2022. “Following the FDA approval of PYRUKYND® for the treatment…

Leggi di più »